Asieris will present Cevira trial data and showcase Hexvix at the IPA congress

Photocure partner Asieris provides an update on three Cevira (APL-1702) presentations, scheduled at the upcoming 19th International Photodynamic Association (IPA) Congress that will convene in Shanghai from June 10-16, 2025. 

IPA 2025 will gather leading scholars, clinical experts, and industry leaders to explore cutting-edge advancements and the vast potential of PDT.During this meeting leading investigators will present APRICITY study efficacy and safety data and discuss latest clinical applications of PDT for cervical intraepithelial lesions. Asieris will also exhibit Hexvix (APL-1706) at this international conference, as it is currently approved in China. 

Read Asieris’ full media release here: https://asieris.com/asieris-to-present-worlds-innovative-photodynamic-products-at-19th-ipa-congress/